METHOD FOR ARCHIVING A MICROBIOME
20190300843 ยท 2019-10-03
Inventors
Cpc classification
C12N1/04
CHEMISTRY; METALLURGY
A23L33/135
HUMAN NECESSITIES
International classification
C12N1/04
CHEMISTRY; METALLURGY
A23L33/135
HUMAN NECESSITIES
Abstract
Methods for archiving and reconstituting a microbiome are disclosed. A method for archiving a microbiome can include collecting a sample including a microbial community defining the microbiome. The method can also include expanding the microbial community in the sample and preserving the sample to provide a preserved sample. Packaging the preserved sample to archive the microbiome can also form part of the method of archiving the microbiome.
Claims
1. A method for archiving a microbiome, the method comprising: collecting a sample including a microbial community defining the microbiome; expanding the microbial community in the sample; preserving the sample to provide a preserved sample; and packaging the preserved sample to archive the microbiome.
2. The method of claim 1, wherein expanding the microbial community in the sample includes providing a microbiome modulator to the sample.
3. The method of claim 2, wherein providing the microbiome modulator to the sample occurs prior to preserving the sample.
4. The method of claim 2, wherein the microbiome modulator comprises a prebiotic that encourages growth of a desired bacteria in the microbial community.
5. The method of claim 4, wherein the microbiome modulator further comprises at least one of a bacteriophage and a predatory bacteria that discourage growth of a non-desired bacteria in the microbial community.
6. The method of claim 1, wherein the sample is preserved by lyophilization.
7. The method of claim 2, wherein packaging the preserved sample includes providing a reconstitution fluid along with the preserved sample, wherein the reconstitution fluid is separate from the preserved sample.
8. The method of claim 7, wherein the microbiome modulator is provided in the reconstitution fluid.
9. The method of claim 7, wherein the packaging is a dual chambered ampoule including a first chamber and a second chamber, the first chamber of the ampoule includes the preserved sample, the second chamber of the ampoule includes the reconstitution fluid.
10. A method for archiving a microbiome, the method comprising: collecting a sample including a microbial community defining the microbiome; providing a microbiome modulator to the sample; preserving the sample to provide a preserved sample; and packaging the preserved sample to archive the microbiome.
11. The method of claim 10, wherein providing the microbiome modulator to the sample occurs prior to preserving the sample.
12. The method of claim 10, wherein the microbiome modulator comprises a prebiotic that encourages growth of a desired bacteria in the microbial community.
13. The method of claim 10, wherein the microbiome modulator comprises at least one of a bacteriophage and a predatory bacteria that discourage growth of a non-desired bacteria in the microbial community.
14. The method of claim 10, wherein the sample is preserved by lyophilization.
15. The method of claim 10, wherein packaging the preserved sample includes providing a reconstitution fluid along with the preserved sample, wherein the reconstitution fluid is separate from the preserved sample.
16. The method of claim 15, wherein the microbiome modulator is provided in the reconstitution fluid.
17. The method of claim 15, wherein the packaging is a dual chambered ampoule including a first chamber and a second chamber, the first chamber of the ampoule includes the preserved sample, the second chamber of the ampoule includes the reconstitution fluid.
18. A method of recreating a microbiome, the method comprising: archiving the microbiome according to the method for archiving a microbiome of claim 10; and reconstituting the preserved sample to recreate the microbiome.
19. A method for archiving a microbiome, the method comprising: collecting a sample including a microbial community defining the microbiome, the microbial community being selected from the group consisting of: nasal, vaginal, skin, oral, bladder, placenta, breast, scalp, ear, eye, kidney, lungs, and nails; preserving the sample by lyophilization to provide a preserved sample; and packaging the preserved sample to archive the microbiome.
20. The method of claim 19, further comprising: providing a microbiome modulator to the sample, the microbiome modulator comprising at least one of a prebiotic, a bacteriophage, and a predatory bacteria, wherein the prebiotic is configured to encourage growth of a desired bacteria in the microbial community, and wherein the bacteriophage and the predatory bacteria are configured to discourage growth of a non-desired bacteria in the microbial community.
Description
DESCRIPTION OF THE DRAWINGS
[0009]
[0010]
[0011]
DETAILED DESCRIPTION
[0012] The present disclosure relates generally to methods of archiving a microbiome. In some embodiments, the microbiome can be reconstituted in preparation for implementing to a patient or consumer for helping restore a desired microbial community. For purposes of this disclosure, reference to patient or consumer or user can be replaceable, as the way an intended user of the method of the present application is referred to due to a particular condition or reason for restoring a microbiome is not meant to limit in any aspects of the disclosure.
[0013] As mentioned above, there are a variety of reasons why a user may want to archive a microbiome. Although some preferred embodiments of the present disclosure relate to archiving a human microbiome, it can be appreciated that the present disclosure is not limited to any specific listing of human microbiomes. Furthermore, it is to be understood that the present disclosure encompasses methods and uses for archiving microbiomes for a variety of other animal and plant species as well as environmental conditions, in addition to human microbiomes. For example, there may be particular interest in archiving one or more microbiomes for pets. Archiving a pet microbiome can be done to reconstitute the microbiome after antibiotic therapy, or possibly, to help restore the microbiome to a more youthful state to help with skin condition or odor problems.
[0014] In one embodiment, a method for archiving a microbiome can include collecting a sample including a microbial community defining the microbiome. Collecting a sample can be achieved in various methods depending on the site the microbial sample is intended to be collected. As an example, an intestinal microbial community defining the microbiome of a patient's intestine can be collected via a feces sample (e.g., a stool sample) in a standard fecal collection vial, as is known in the art. For vaginal, skin, nasal, and other body parts, standard microbial specimen swabs can be used. Other collection mechanisms/methods that can be used can include: washes and collection with wipes, vacuum, use of dry absorbents (SAM), and particles (e.g., clay, vermiculite, charcoal). Any suitable collection method or means of collecting a sample including a microbial community defining the microbiome is within the scope of this disclosure.
[0015] Upon collecting a sample including the microbial community defining the microbiome, the sample can be temporarily stored to preserve the integrity of the sample. For example, in some embodiments, the sample can be stored in a sealed bag or vial and placed in a standard refrigerator or freezer. Potential storage techniques can include the use of desiccants, osmolites, and chilling with endothermic substrates. It is to be understood that one of ordinary skill in the art understands the appropriate collection equipment and methodology for collecting a sample that will include a microbial community representative of and defining the intended microbiome, as well as proper storage techniques for preserving the integrity of the sample. In some embodiments, the microbial community can be collected in a user's home. In other embodiments, the microbial community can be collected at a medical facility or professional facility. However, the location of where or how the microbial sample is collected is not meant to limit the present disclosure.
[0016] In some embodiments, the sample can be transported to a professional facility for further processing and archiving. For example, if the sample is collected at a user's home, the sample can be transported to a facility for further processing and archiving. In such situations, a user can be provided with a kit 10 that includes the appropriate collection and temporary storage equipment to preserve the integrity of the sample before transporting the sample to a professional facility. As one example,
[0017] Additionally, the method for archiving a microbiome can also include preserving the sample including the microbial community defining the microbiome after the sample is collected to provide a preserved sample. In a preferred embodiment, the sample can be preserved through lyophilization. Lyophilization is a freeze drying process in which water can be removed from the sample after it is frozen and placed under a vacuum. Lyophilization techniques for preserving microbial samples are known by one of ordinary skill in the art. A benefit of lyophilization is that it allows the sample to be stored for long periods of time without the use of cryogenic fluid or freezing the samples in liquid. Lyophilization provides greater dryness than the use of desiccants alone. However, it is contemplated in this disclosure that desiccants can also be utilized to reduce moisture.
[0018] The preserved sample can also be packaged to archive the microbiome. The preserved sample can be packaged in a variety of containers, including, but not limited to, vials, bottles, tubes, bags, receptacles, and ampoules. In a preferred embodiment, the preserved sample can be packaged in a dual chambered ampoule 18, as shown in
[0019] In some preferred embodiments, the method for archiving a microbiome can include expanding the microbial sample that defines the microbiome. Expanding the microbial sample can be accomplished by introducing a microbiome modulator to the sample. A microbiome modulator can expand the microbial community by encouraging growth of a desired bacteria in the microbial community. In some embodiments, the microbiome modulator could comprise a prebiotic. For instance, for the vaginal microbiome, a media such as LAPTg may be used that has been demonstrated to support growth of lactobacilli and other Gram negative and Gram positive organisms typically found in the vagina. The expansion can be done in low oxygen conditions (e.g., about 2%), which mimic conditions in the vagina. Addition of microbiome modulators like the prebiotic inulin could be used to preferably grow Lactobacillus spp that are known to be beneficial in the vaginal canal. Prebiotics that could be used to encourage growth of Lactobaccilus spp include saccharides that may not be digestible by humans but are useful prebiotics within the scope of the present disclosure and can include, but are not limited to, transgalactooligosaccharides, galacto-oligosaccharides, lactulose, raffinose, stachyose, lactosucrose, fructo-oligosaccharides, isomalto-oligosaccharides, xylo-oligosaccharides, paratinose oligosaccharides, difructose anhydride III, sorbitol, maltitol, lactitol, reduced paratinose, cellulose, -glucose, -galactose, -fructose, verbascose, galactinol, and -glucan, guar gum, pectin, high sodium alginate, and lambda carrageenan.
[0020] It is preferable to expand the microbial sample prior to preserving the sample, however, it is contemplated that the microbial sample could be expanded after the sample is preserved and archived as part of reconstituting the microbiome, as will be further discussed below. It is also contemplated that the microbial sample can be expanded both prior to preserving the sample and after preserving the microbial sample during reconstituting the microbiome.
[0021] Additionally or alternatively, the microbiome modulator can also discourage growth of a non-desired bacteria in the microbial community of the sample. For example, a microbiome modulator such as xylitol may be used to discourage the growth of Streptococcus in the oral microbiome. Additionally, the microbiome modulator can include a bacteriophage and/or a predatory bacteria that discourage growth of a non-desired bacteria in the microbial community of the sample. One example of a predatory bacteria could include Bdellovibrio bacteriovorus that are known to prey on Gram negative pathogens. Exemplary bacteriophage that can discourage growth of non-desired bacteria can include Staphylococcal Myoviridae (e.g. phages K, G1, Twort), Pseudomonas PAK-P1 bacteriophage, and Enterobacteria phage T4. Such bacteriophage and/or predatory bacteria could be useful for discouraging growth of non-desired bacteria in a variety of microbial communities, including, but not limited to, the skin, nasal, scalp, perianal, and toe. Of course, other bacteriophage and predatory bacteria that discourage growth of a non-desired bacteria in the microbial community of the sample are within the scope of this disclosure.
[0022] As discussed above, it can be preferable to discourage growth of a non-desired bacteria prior to preserving the sample, however, it is contemplated that the microbial sample could be provided with a microbiome modulator that discourages growth of a non-desired bacteria after the sample is preserved and archived as part of reconstituting the microbiome, as will be further discussed below. It is also contemplated that the microbial sample can be provided with a microbiome modulator that discourages growth of a non-desired bacteria both prior to preserving the sample and after preserving the microbial sample during reconstituting the microbiome.
[0023] As illustrated in
[0024] As depicted in
[0025] The preserved sample including the microbial community defining the microbiome can be reconstituted after the sample is archived. As noted above, some preservation methods, such as lyophilization, may allow for the preserved sample to be archived and remain stable for upwards of 50 years, even in a user's home. In the embodiment depicted in
[0026] The dual chambered ampoule 18 can form part of the kit 10 discussed above and depicted in
[0027] Archiving a microbiome can have a wide variety of applications within the human body. For example, microbiomes that a user may desire to archive for potential benefit at a later time can include, but are not limited to: gut/intestinal, nasal, vaginal, skin, oral, bladder, placenta, breast, scalp, ear, eye, kidney, lungs, and nails. A user may wish to reconstitute and use such a microbiome for maternal transfer or vaginal seeding for C-sections or for fecal transplants. Other potential reasons for reconstituting and using such microbiomes could be for cosmetic reasons, such as seeding the skin with a younger microbiome. Additionally, specific species within a microbial community may be restored that may have been lost to some events such as antibiotic therapy, chemotherapy, radiation, or other events. There may also be similar uses for species other than humans, for example, particularly with pets. Additional benefits could be for livestock such as dairy cows, horses, beef cattle, pigs, and chickens for increased production and health.
EMBODIMENTS
[0028] Embodiment 1: A method for archiving a microbiome, the method comprising: collecting a sample including a microbial community defining the microbiome; expanding the microbial community in the sample; preserving the sample to provide a preserved sample; and packaging the preserved sample to archive the microbiome.
[0029] Embodiment 2: The method of embodiment 1, wherein expanding the microbial community in the sample includes providing a microbiome modulator to the sample.
[0030] Embodiment 3: The method of embodiment 2, wherein providing the microbiome modulator to the sample occurs prior to preserving the sample.
[0031] Embodiment 4: The method of embodiment 2 or embodiment 3, wherein the microbiome modulator comprises a prebiotic that encourages growth of a desired bacteria in the microbial community.
[0032] Embodiment 5: The method of embodiment 4, wherein the microbiome modulator further comprises at least one of a bacteriophage and a predatory bacteria that discourage growth of a non-desired bacteria in the microbial community.
[0033] Embodiment 6: The method of any one of the preceding embodiments, wherein the sample is preserved by lyophilization.
[0034] Embodiment 7: The method of any one of the preceding embodiments, wherein packaging the preserved sample includes providing a reconstitution fluid along with the preserved sample, wherein the reconstitution fluid is separate from the preserved sample.
[0035] Embodiment 8: The method of embodiment 7, wherein the microbiome modulator is provided in the reconstitution fluid.
[0036] Embodiment 9: The method of embodiment 7 or embodiment 8, wherein the packaging is a dual chambered ampoule including a first chamber and a second chamber, the first chamber of the ampoule includes the preserved sample, the second chamber of the ampoule includes the reconstitution fluid.
[0037] Embodiment 10: A method for archiving a microbiome, the method comprising: collecting a sample including a microbial community defining the microbiome; providing a microbiome modulator to the sample;
[0038] preserving the sample to provide a preserved sample; and packaging the preserved sample to archive the microbiome.
[0039] Embodiment 11: The method of embodiment 10, wherein providing the microbiome modulator to the sample occurs prior to preserving the sample.
[0040] Embodiment 12: The method of embodiment 10 or embodiment 11, wherein the microbiome modulator comprises a prebiotic that encourages growth of a desired bacteria in the microbial community.
[0041] Embodiment 13: The method of any one of embodiments 10-12, wherein the microbiome modulator comprises at least one of a bacteriophage and a predatory bacteria that discourage growth of a non-desired bacteria in the microbial community.
[0042] Embodiment 14: The method of any one of embodiments 10-13, wherein the sample is preserved by lyophilization.
[0043] Embodiment 15: The method of any one of embodiments 10-14, wherein packaging the preserved sample includes providing a reconstitution fluid along with the preserved sample, wherein the reconstitution fluid is separate from the preserved sample.
[0044] Embodiment 16: The method of embodiment 15, wherein the microbiome modulator is provided in the reconstitution fluid.
[0045] Embodiment 17: The method of embodiment 15 or 16, wherein the packaging is a dual chambered ampoule including a first chamber and a second chamber, the first chamber of the ampoule includes the preserved sample, the second chamber of the ampoule includes the reconstitution fluid.
[0046] Embodiment 18: A method of recreating a microbiome, the method comprising: archiving the microbiome according to the method for archiving a microbiome of any of the preceding embodiments; and reconstituting the preserved sample to recreate the microbiome.
[0047] Embodiment 19: A method for archiving a microbiome, the method comprising: collecting a sample including a microbial community defining the microbiome, the microbial community being selected from the group consisting of: nasal, vaginal, skin, oral, bladder, placenta, breast, scalp, ear, eye, kidney, lungs, and nails; preserving the sample by lyophilization to provide a preserved sample; and packaging the preserved sample to archive the microbiome.
[0048] Embodiment 20: The method of embodiment 19, further comprising: providing a microbiome modulator to the sample, the microbiome modulator comprising at least one of a prebiotic, a bacteriophage, and a predatory bacteria, wherein the prebiotic is configured to encourage growth of a desired bacteria in the microbial community, and wherein the bacteriophage and the predatory bacteria are configured to discourage growth of a non-desired bacteria in the microbial community.
[0049] While the invention has been described in detail with respect to the specific embodiments thereof, it will be appreciated that those skilled in the art, upon attaining an understanding of the foregoing, may readily conceive of alterations to, variations of, and equivalents to these embodiments. Accordingly, the scope of the present disclosure should be assessed as that of the appended claims and any equivalents thereto.